2022. Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: Pooled Results From Phase 3 Trials (DERMIS-1 and DERMIS-2). SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s57. DOI:https://doi.org/10.25251/skin.6.supp.57.